Assura Group
Assura Group Limited is listed on the London Stock Exchange and is a health provider organisation that invests in and develops primary health care property, community hospitals, integrated pharmacy and related medical businesses incorporating joint venture partnerships with GPs, consultants, diagnostics and service providers. Assura Group Limited has three operating divisions: Assura Medical Limited, Assura Property Limited and Assura Pharmacy Limited.
Assura Group placing successful, raises £30 mln of new equity
UK healthcare group Assura Group Ltd said it has successfully placed 81,081,080 new ordinary shares at 37 pence each on the London Stock Exchange, raising £30 million of new equity.
Chief executive Richard Burrell said: "We are delighted to announce the completion of the placing in this extremely challenging economic environment and are grateful for the support from our shareholders.
“The funds from the placing, together with the £50 million banking facility negotiated in October, ensure that Assura is well positioned to focus on its investment in its medical operating business and to take advantage of the opportunities that arise as the provision of NHS primary care services is increasingly opened up to the private sector,” he added.
All directors except non-executive Graham Chase took up further shares in the placing. Chairman Rodney Baker-Bates took a further 108,108 shares, raising his holding to 213,827 shares, or 0.067 percent, while his deputy John Curran increased his holding by 40,203 shares to 455,203, or 0.143 percent.
Chief executive Richard Burrell increased his stake to 4.045 percent by taking 1,703,481 new shares. He now holds 12,842,110 shares. Chief financial officer Nigel Rawlings took up 121,622 new shares and now holds 1,512,939 shares or 0.476 percent.
Register here to be notified of future Assura Group articles.